{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:06Z","timestamp":1787065326379,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health Disability and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025520","name":"Medical Research Future Fund","doi-asserted-by":"publisher","award":["2015305"],"award-info":[{"award-number":["2015305"]}],"id":[{"id":"10.13039\/501100025520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128501","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T04:03:08Z","timestamp":1774238588000},"page":"128501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia"],"prefix":"10.1016","volume":"79","author":[{"given":"Lucy","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khanlari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isis","family":"Maitland-Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Wee","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Hissaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Melody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Chunilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Buttery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel","family":"Clothier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel W.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linny","family":"Phuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Pepperell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Effler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Macartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.vaccine.2026.128501_bb0005","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2026.128501_bb0010","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128501_bb0015","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.vaccine.2024.01.045","article-title":"Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data","volume":"42","author":"Sch\u00f6nborn","year":"2024","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128501_bb0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1001\/jamaneurol.2021.3619","article-title":"Characteristics and outcomes of patients with cerebral venous sinus thrombosis in SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"78","author":"S\u00e1nchez van Kammen","year":"2021","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128501_bb0025","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00491-z","article-title":"Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis","volume":"7","author":"Kehr","year":"2022","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128501_bb0030","article-title":"The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study","volume":"40","author":"Tran","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2026.128501_bb0035","author":"Department of Health DaA"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128501_bb0040","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ana.26172","article-title":"COVID-19 vaccine-associated cerebral venous thrombosis in Germany","volume":"90","author":"Schulz","year":"2021","journal-title":"Ann Neurol"},{"issue":"16","key":"10.1016\/j.vaccine.2026.128501_bb0045","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1182\/blood.2021014684","article-title":"Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis","volume":"139","author":"Craven","year":"2022","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128501_bb0050","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.jtha.2023.06.027","article-title":"Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Sch\u00f6nborn","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128501_bb0055","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1161\/STROKEAHA.122.039575","article-title":"Outcomes of cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after the acute phase","volume":"53","author":"van de Munckhof","year":"2022","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128501_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072658","article-title":"Living with vaccine-induced immune thrombocytopenia and thrombosis: a qualitative study","volume":"13","author":"Bennett","year":"2023","journal-title":"BMJ Open"},{"issue":"Supplement 1","key":"10.1016\/j.vaccine.2026.128501_bb0065","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.1182\/blood-2024-207893","article-title":"Quality of life, physical and mental health of patients with vaccine induced immune thrombotic thrombocytopenia after extended followup","volume":"144","author":"Karunakaran","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128501_bb0070","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60. II Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scott Med J"},{"key":"10.1016\/j.vaccine.2026.128501_bb0075","unstructured":"Weathers FW, Litz BT, Keane TM, Palmieri PA, Marx BP, Schnurr PP. The PTSD checklist for DSM-5 (PCL-5). National Center for PTSD2013 [Available from: https:\/\/www.ptsd.va.gov\/professional\/assessment\/adult-sr\/ptsd-checklist.asp."},{"issue":"9","key":"10.1016\/j.vaccine.2026.128501_bb0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128501_bb0085","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128501_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2026.128501_bb0095","series-title":"Findings from autumn 2004 health omnibus survey","author":"Harrison Health Research","year":"2004"},{"key":"10.1016\/j.vaccine.2026.128501_bb0100","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128501_bb0105","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.2021014214","article-title":"Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient","volume":"139","author":"Sch\u00f6nborn","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2026.128501_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.thromres.2023.01.017","article-title":"Long VITT: a case report","volume":"223","author":"Roberge","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.vaccine.2026.128501_bb0115","article-title":"Thrombocytopenic, thromboembolic and haemorrhagic events following second dose with BNT162b2 and ChAdOx1: self-controlled case series analysis of the English national sentinel cohort","volume":"32","author":"Joy","year":"2023","journal-title":"Lancet Reg Health \u2013 Europe"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128501_bb0120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/camh.12501","article-title":"Review: mental health impacts of the COVID-19 pandemic on children and youth - a systematic review","volume":"27","author":"Samji","year":"2022","journal-title":"Child Adolesc Mental Health"},{"key":"10.1016\/j.vaccine.2026.128501_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2024.115972","article-title":"Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: results from the international COH-FIT study","volume":"342","author":"Solmi","year":"2024","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128501_bb0130","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1017\/S0033291721001963","article-title":"Changes in mental health and help-seeking among young Australian adults during the COVID-19 pandemic: a prospective cohort study","volume":"53","author":"Upton","year":"2023","journal-title":"Psychol Med"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128501_bb0135","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afad170","article-title":"The mental health impact of the COVID-19 pandemic on older adults: a systematic review and meta-analysis","volume":"52","author":"Sch\u00e4fer","year":"2023","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128501_bb0140","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1186\/s12889-021-12092-x","article-title":"Declines in health literacy and health-related quality of life during the COVID-19 pandemic: a longitudinal study of the Japanese general population","volume":"21","author":"Ishikawa","year":"2021","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128501_bb0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/PSY.0000000000000871","article-title":"Mental health during COVID-19 lockdown in the United Kingdom","volume":"83","author":"Pieh","year":"2021","journal-title":"Psychosom Med"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128501_bb0150","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s11136-023-03414-0","article-title":"Health-related quality of life before and during the COVID-19 pandemic in Switzerland: a cross-sectional study","volume":"32","author":"Roser","year":"2023","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128501_bb0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa2514824","article-title":"Adenoviral inciting antigen and somatic hypermutation in VITT","volume":"394","author":"Wang","year":"2026","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:51:54Z","timestamp":1781308314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"alternative-id":["S0264410X26003099"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128501","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128501"}}